2021 annual financial data
TG Therapeutics 2021 Net margin
TG Therapeutics 2021 net margin with verified reported values.
Direct answer
Net margin was -5,204.08%.
Operating income was -344,770,000 USD and net income was -348,101,000 USD.
Operating cash flow was -295,634,000 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,689,000 USD
- Operating income
- -344,770,000 USD
- Net income
- -348,101,000 USD
- Operating cash flow
- -295,634,000 USD